ANIX logo

ANIX Anixa Biosciences, Inc.

NASDAQ Capital Market · Biotechnology · Healthcare

$2.82
-0.08 (-2.70%)

Anixa Biosciences, Inc. (ANIX) is a biotechnology company dedicated to pioneering therapies and vaccines. Its core mission revolves around addressing critical, unmet medical needs, particularly within the fields of oncology (cancer) and infectious diseases. Among its therapeutic pipeline, Anixa is developing a novel chimeric endocrine receptor T-cell (CER-T) technology, an innovative adaptation of…

Market Cap: $96.01Mwww.anixa.com

Price

No data yet.

Social Signal Score

30
5d
31
1 mentions
30d
30
1 mentions
60d
30
1 mentions
90d
30
1 mentions
news: 1

Revenue

$0.00-100.00%
$0.00$250.0K$500.0K$750.0K
Jul 2016Apr 2026

Analyst Estimates

FY2025
$-0.36
$-0.36$-0.36
1 analysts
FY2026
$-0.32
$-0.32$-0.32
1 analysts
FY2027
$-0.33
$-0.33$-0.33
2 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Amit Kumar
Sector
Healthcare
Industry
Biotechnology
Employees
4
Beta
0.60
Country
US
Piotroski score
2 / 9 (Weak)
Altman Z-score
10.71
www.anixa.com